共 117 条
- [61] MCDONALD F, 1995, DRUG DEV IND PHARM, V21, P2403
- [62] MEIER A, 1956, Pharm Acta Helv, V31, P177
- [63] MISHIMA S., 1966, INVEST OPHTHALMOL, V5, P264
- [64] DROP SIZE AND SYSTEMIC ADVERSE-EFFECTS IN TIMOLOL OPHTHALMIC SOLUTION [J]. DICP-THE ANNALS OF PHARMACOTHERAPY, 1990, 24 (04): : 439 - 440
- [65] Morlet N, 1996, J Ophthalmic Nurs Technol, V15, P60
- [66] Morlet N, 1997, OPHTHALMIC SURG LAS, V28, P687
- [68] SYSTEMIC SIDE-EFFECTS ASSOCIATED WITH THE OPHTHALMIC ADMINISTRATION OF TIMOLOL [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (02): : 85 - 89
- [69] NELSON JD, 1987, AM J OPHTHALMOL, V103, P333
- [70] Nordenskiold U, 1997, Scand J Rehabil Med Suppl, V37, P1